CTOs on the Move

Neuralstem

www.neuralstem.com

 
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.neuralstem.com
  • 20271 Goldenrod Lane 2nd Floor
    Germantown, MD USA 20876
  • Phone: 301.366.4960

Executives

Name Title Contact Details

Similar Companies

Florence Crittendon Services of Charlotte, NC

Florence Crittendon Services of Charlotte, NC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Charlotte, NC. To find more information about Florence Crittendon Services of Charlotte, NC, please visit www.fcsnc.org

MedcomSoft

MedcomSoft Inc. (MedcomSoft) is a developer and distributor of software solutions to the healthcare industry in Canada and United States. The Company develops, markets, licenses and supports healthcare software solutions to the office-based or ambulatory

Hartford Neurology

Hartford Neurology is a Bloomfield, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardinal Innovations

Cardinal Innovations Healthcare is the leading provider of managed care services in the U.S. Cardinal Innovations, the nations largest specialty health plan and the pioneer of a unique managed healthcare model, incorporates a community-based model of care management, a network of highly-skilled providers and local support partners to improve the health and wellness of plan members. Cardinal Innovations serves members through Medicaid, state and county-funded plans and supports a variety of initiatives for Veterans and their families through centralized call center services and other collaborative initiatives.

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.